Question

Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the com2022 f. In March, paid the entire amount of the note on its March 1 due date, using proceeds from a February issuance of $25.

0 0
Add a comment Improve this question Transcribed image text
Answer #1

Requirement 1) Journal entries : Camden Biotechnology

Transaction Date Account tittles and explanation Debit Credit
a. 2021 No entry required
b. Cash a/c $28000000
To notes payable a/c $28000000
c. Cash a/c $2700
To Liability for refundable deposits a/c $2700
d.

Accounts receivable a/c

{Bal}

$5342400
To sales revenue a/c $5040000

To sales tax payable a/c

{$5040000*6%}

$302400
e.

Interest expense a/c

{$28000000*9%*(3/12)}

$630000

To interest payable a/c

$630000
2022
f. Cash a/c $25400000
To bonds payable a/c $25400000
g. Notes payable a/c $28000000
Interest payable a/c $630000

Interest expense a/c

{28000000*9%*(2/12)}

$420000
To Cash a/c $29050000
h.

Liability for refundable deposits a/c

{$2700*(1/2)}

$1350
To Cash a /c $1350

Requirement 2) Current and Long term liability sections of the December 31,2021, Balance Sheet

Particulars Amount($)
Current liabilities
Accounts payable 262000

Current portion of notes payable

{$28 million - $25.4 million}

2600000
Sales tax payable 302400
Interest payable 630000
Liability for refundable deposits 2700
Total current liabilities 3797100
Long term liabilities
Note payable 25400000

​​​​​​------------*-----------

DO VOTE, ALL THE BEST

HAPPY CHEGGING

Add a comment
Know the answer?
Add Answer to:
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for? Ask your own homework help question. Our experts will answer your question WITHIN MINUTES for Free.
Similar Homework Help Questions
  • Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...

    Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $10,000,000 at the bank's prime rate (12.5% at the time). The company will pay no commitment fees. b. On October 1,...

  • Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...

    Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022 Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $16,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...

  • Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...

    Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $33,000,000 at the bank's prime rate (15.5% at the time). The company will pay no commitment fees. b. On October 1,...

  • Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...

    Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $20,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...

  • Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...

    Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $20,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...

  • Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...

    Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $16,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...

  • Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...

    Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $23,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...

  • Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...

    Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2021 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $20,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. On October 1, borrowed $17...

  • Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...

    Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2021 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $17,000,000 at the bank's prime rate (12.5% at the time). The company will pay no commitment fees. On October 1, borrowed $14...

  • Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...

    Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2021 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $27,000,000 at the bank's prime rate (12.5% at the time). The company will pay no commitment fees. b. On October 1,...

ADVERTISEMENT
Free Homework Help App
Download From Google Play
Scan Your Homework
to Get Instant Free Answers
Need Online Homework Help?
Ask a Question
Get Answers For Free
Most questions answered within 3 hours.
ADVERTISEMENT
ADVERTISEMENT
Active Questions
ADVERTISEMENT